5-MeS-DMT

Last updated
5-MeS-DMT
5-MeS-DMT.svg
Names
Preferred IUPAC name
N,N-Dimethyl-2-[5-(methylsulfanyl)-1H-indol-3-yl]ethan-1-amine
Other names
5-Methylthio-N,N-dimethyltryptamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
PubChem CID
UNII
  • InChI=1S/C13H18N2S/c1-15(2)7-6-10-9-14-13-5-4-11(16-3)8-12(10)13/h4-5,8-9,14H,6-7H2,1-3H3 Yes check.svgY
    Key: YOGJZQGRTVMCPY-UHFFFAOYSA-N Yes check.svgY
  • InChI=1/C13H18N2S/c1-15(2)7-6-10-9-14-13-5-4-11(16-3)8-12(10)13/h4-5,8-9,14H,6-7H2,1-3H3
    Key: YOGJZQGRTVMCPY-UHFFFAOYAL
  • CN(CCC1=CNC2=C1C=C(SC)C=C2)C
Properties
C13H18N2S
Molar mass 234.36 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X mark.svgN  verify  (what is  Yes check.svgYX mark.svgN ?)

5-MeS-DMT (5-methylthio-N,N-dimethyltryptamine) is a lesser-known psychedelic drug. It is the 5-methyl thio analog of dimethyltryptamine (DMT). 5-MeS-DMT was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), the minimum dosage is listed as 15-30 mg. [1] The duration listed as very short (less than one hour), just like DMT. 5-MeS-DMT produces similar effects to DMT, but weaker. Shulgin describes his feelings while on a low dose of this drug as "pointlessly stoned", although at a higher dose of 20 mg he says it is "quite intense" and suggests that a higher dose still might have full activity.

5-MeS-DMT has been the subject of only limited clinical testing, with several small behavioral studies in rats indicating that it is a less potent than 5-MeO-DMT or 4-hydroxy-DMT (psilocin) but more effective than either 4-MeO-DMT or 4-MeS-DMT. [2] [3] [4]

See also

References

  1. ↑ 5-MeS-DMT Entry in TIHKAL
  2. ↑ Glennon, R.A.; Young, R.; Benington, F.; Morin, R.D. (February 1982). "Hallucinogens as discriminative stimuli: A comparison of 4-OMe and 5-OMe DMT with their methylthio counterparts". Life Sciences. 30 (5): 465–467. doi:10.1016/0024-3205(82)90463-5. PMID   6801410.
  3. ↑ Kline TB; Benington F; Morin RD; Beaton JM (August 1982). "Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety". Journal of Medicinal Chemistry. 25 (8): 908–13. doi:10.1021/jm00350a005. PMID   7120280.
  4. ↑ Kline TB; Benington F; Morin RD; Beaton JM; Glennon RA; Domelsmith LN; Houk KN; Rozeboom MD (November 1982). "Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives". Journal of Medicinal Chemistry. 25 (11): 1381–3. doi:10.1021/jm00353a021. PMID   6815326.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.